|
Market Closed -
London S.E.
16:22:35 24/10/2025 +04
|
After hours 19:25:00 | |||
| 6.451 SEK | -23.88% |
|
4.093 | -36.55% |
Company Valuation: Active Biotech AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 275.5 | 254.8 | 165.1 | 115.9 | 121.3 | 108.2 | - | - |
| Change | - | -7.51% | -35.2% | -29.8% | 4.6% | -10.76% | - | - |
| Enterprise Value (EV) | 223.1 | 254.8 | 128.9 | 88.53 | 121.3 | 108.2 | 108.2 | 108.2 |
| Change | - | 14.2% | -49.4% | -31.34% | 36.97% | -10.76% | 0% | 0% |
| P/E | - | - | - | - | - | - | - | - |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | - | - | - | - | - | -6.6x |
| EV / Revenue | - | - | - | - | - | - | - | -6.6x |
| EV / EBITDA | -0x | -0x | -0x | -0x | -0x | -3.11x | 6.52x | 2.16x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -3.26x | 5.95x | 2.09x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | - | - | - | - | - | - | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | - | -16.4 |
| EBITDA 1 | -48.5 | -56.4 | -44.8 | -38.2 | -36 | -34.8 | 16.6 | 50.2 |
| EBIT 1 | -49.8 | -57.9 | -46.5 | -39.8 | -37.6 | -33.2 | 18.2 | 51.8 |
| Net income 1 | -49.8 | -58.4 | -45.8 | -39.4 | -37.32 | -33.2 | 18.2 | 51.8 |
| Net Debt | -52.37 | - | -36.2 | -27.4 | - | - | - | - |
| Reference price 2 | 126.400 | 96.200 | 45.650 | 10.880 | 4.600 | 4.370 | 4.370 | 4.370 |
| Nbr of stocks (in thousands) | 2,180 | 2,649 | 3,617 | 10,655 | 26,361 | 26,361 | - | - |
| Announcement Date | 25/03/22 | 09/02/23 | 08/02/24 | 13/02/25 | 01/04/26 | - | - | - |
1SEK in Million2
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 20.78x | 7.3x | 14.73x | 1.43% | 70.88B | |
| 48.85x | 9.38x | 29.23x | 0.04% | 62.49B | |
| 30.44x | 6.47x | 16.8x | -.--% | 26.34B | |
| -73.25x | 14.16x | -68.28x | -.--% | 26.21B | |
| -14.7x | 5.35x | -6.73x | -.--% | 24.13B | |
| 28.25x | 5.33x | 17.72x | -.--% | 20.72B | |
| 45.45x | 16.69x | 33.86x | 0.33% | 15.69B | |
| 18.03x | 5.37x | 12.55x | -.--% | 14.46B | |
| -15.41x | 3481.82x | -17.8x | -.--% | 14.24B | |
| Average | 9.83x | 394.65x | 3.56x | 0.2% | 30.57B | |
| Weighted average by Cap. | 15.96x | 188.28x | 7.95x | 0.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ACTI Stock
- 0GQU Stock
- Valuation Active Biotech AB
Select your edition
All financial news and data tailored to specific country editions
